rebel Financial rebel Financial
← All Posts
REG

REGENXBIO Inc.

May 30, 2026 Author: Phil Ratcliff
Item Proposal Vote
1 To elect Jean Bennett, M.D., Ph.D., A.N. “Jerry” Karabelas, Ph.D., and Daniel Tassé, to serve as Class II directors until the 2029 annual meeting of stockholders ✓ For
2 To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2026 ✓ For
3 To hold an advisory vote on the compensation paid to the Company’s named executive officers ✓ For
4 To approve a stock option exchange for our non-executive employees ✓ For
5 To approve a stock option exchange for our executive employees ✓ For
Attachments
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.